5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | NEUTRAL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.93▲ | 8.01▼ | 8.06▼ | 8.20▼ | 7.84▲ |
MA10 | 7.96▼ | 8.08▼ | 8.17▼ | 8.08▼ | 6.72▲ |
MA20 | 8.04▼ | 8.17▼ | 8.16▼ | 8.00▼ | 6.62▲ |
MA50 | 8.16▼ | 8.23▼ | 8.15▼ | 6.63▲ | 5.95▲ |
MA100 | 8.20▼ | 8.09▼ | 8.07▼ | 6.57▲ | 7.31▲ |
MA200 | 8.12▼ | 8.05▼ | 7.39▲ | 5.92▲ | 7.38▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | -0.030▼ | -0.037▼ | -0.059▼ | 0.252▲ |
RSI | 40.667▼ | 37.243▼ | 40.898▼ | 56.318▲ | 62.284▲ |
STOCH | 36.062 | 9.016▼ | 14.740▼ | 55.887 | 82.888▲ |
WILL %R | -55.102 | -77.083▼ | -77.083▼ | -72.477 | -19.554▲ |
CCI | -55.945 | -169.741▼ | -180.097▼ | -41.137 | 119.573▲ |
Tuesday, May 13, 2025 04:15 AM
Adherex Technologies Inc. (FENC) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.41 per share a year ago.
|
Monday, May 12, 2025 05:00 PM
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q1 2025 Earnings Call Transcript May 13, 2025 Fennec Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.12.
|
Sunday, April 06, 2025 02:20 AM
We feel now is a pretty good time to analyse Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) business as it appears the company may be on the cusp of a considerable accomplishment. Fennec ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 8.17 | 8.275 | 7.83 | 7.93 | 65,055 |
12/06/25 | 8.15 | 8.40 | 8.00 | 8.32 | 84,237 |
11/06/25 | 8.40 | 8.4175 | 7.88 | 8.20 | 73,097 |
10/06/25 | 8.14 | 8.43 | 8.14 | 8.305 | 37,942 |
09/06/25 | 8.41 | 8.49 | 8.1001 | 8.25 | 76,323 |
06/06/25 | 7.99 | 8.72 | 7.975 | 8.43 | 120,964 |
05/06/25 | 7.63 | 7.95 | 7.63 | 7.90 | 61,603 |
04/06/25 | 8.23 | 8.23 | 7.64 | 7.675 | 105,445 |
03/06/25 | 7.87 | 8.06 | 7.73 | 7.875 | 54,180 |
02/06/25 | 8.15 | 8.28 | 7.85 | 7.93 | 161,993 |
|
|
||||
|
|
||||
|
|